#FORMAT=WebAnno TSV 3.2
#T_SP=webanno.custom.Diy_coref|
#T_RL=webanno.custom.Diy_coref_re|BT_webanno.custom.Diy_coref


#Text=[0010] Although double fractionation of plasma is performed here, the erythrocyte concentrate is returned to the blood donor again directly without interim storage.
#Text=[0011] EP 349 188 describes a method for separating blood into blood components, and a separator unit for recovering these blood components.
1-1	0-1	[	_	_	
1-2	1-5	0010	_	_	
1-3	5-6	]	_	_	
1-4	7-15	Although	_	_	
1-5	16-22	double	_	_	
1-6	23-36	fractionation	_	_	
1-7	37-39	of	_	_	
1-8	40-46	plasma	_	_	
1-9	47-49	is	_	_	
1-10	50-59	performed	_	_	
1-11	60-64	here	_	_	
1-12	64-65	,	_	_	
1-13	66-69	the	_	_	
1-14	70-81	erythrocyte	_	_	
1-15	82-93	concentrate	_	_	
1-16	94-96	is	_	_	
1-17	97-105	returned	_	_	
1-18	106-108	to	_	_	
1-19	109-112	the	_	_	
1-20	113-118	blood	_	_	
1-21	119-124	donor	_	_	
1-22	125-130	again	_	_	
1-23	131-139	directly	_	_	
1-24	140-147	without	_	_	
1-25	148-155	interim	_	_	
1-26	156-163	storage	_	_	
1-27	163-164	.	_	_	
1-28	165-166	[	_	_	
1-29	166-170	0011	_	_	
1-30	170-171	]	_	_	
1-31	172-174	EP	_	_	
1-32	175-178	349	_	_	
1-33	179-182	188	_	_	
1-34	183-192	describes	_	_	
1-35	193-194	a	*[1]	2-3[2_1]	
1-36	195-201	method	*[1]	_	
1-37	202-205	for	*[1]	_	
1-38	206-216	separating	*[1]	_	
1-39	217-222	blood	*[1]	_	
1-40	223-227	into	*[1]	_	
1-41	228-233	blood	*[1]	_	
1-42	234-244	components	*[1]	_	
1-43	244-245	,	_	_	
1-44	246-249	and	_	_	
1-45	250-251	a	_	_	
1-46	252-261	separator	_	_	
1-47	262-266	unit	_	_	
1-48	267-270	for	_	_	
1-49	271-281	recovering	_	_	
1-50	282-287	these	_	_	
1-51	288-293	blood	_	_	
1-52	294-304	components	_	_	
1-53	304-305	.	_	_	

#Text=According to this method, blood is first conveyed from a whole-blood container through a filter which removes leukocytes and also blood platelets.
2-1	306-315	According	_	_	
2-2	316-318	to	_	_	
2-3	319-323	this	*[2]	_	
2-4	324-330	method	*[2]	_	
2-5	330-331	,	_	_	
2-6	332-337	blood	_	_	
2-7	338-340	is	_	_	
2-8	341-346	first	_	_	
2-9	347-355	conveyed	_	_	
2-10	356-360	from	_	_	
2-11	361-362	a	_	_	
2-12	363-374	whole-blood	_	_	
2-13	375-384	container	_	_	
2-14	385-392	through	_	_	
2-15	393-394	a	_	_	
2-16	395-401	filter	_	_	
2-17	402-407	which	_	_	
2-18	408-415	removes	_	_	
2-19	416-426	leukocytes	_	_	
2-20	427-430	and	_	_	
2-21	431-435	also	_	_	
2-22	436-441	blood	_	_	
2-23	442-451	platelets	_	_	
2-24	451-452	.	_	_	

#Text=The filtered blood is then collected in a primary bag which is then subjected to centrifugation to divide the blood up into a plasma fraction and an erythrocyte concentrate.
3-1	453-456	The	_	_	
3-2	457-465	filtered	_	_	
3-3	466-471	blood	_	_	
3-4	472-474	is	_	_	
3-5	475-479	then	_	_	
3-6	480-489	collected	_	_	
3-7	490-492	in	_	_	
3-8	493-494	a	_	_	
3-9	495-502	primary	_	_	
3-10	503-506	bag	_	_	
3-11	507-512	which	_	_	
3-12	513-515	is	_	_	
3-13	516-520	then	_	_	
3-14	521-530	subjected	_	_	
3-15	531-533	to	_	_	
3-16	534-548	centrifugation	_	_	
3-17	549-551	to	_	_	
3-18	552-558	divide	_	_	
3-19	559-562	the	_	_	
3-20	563-568	blood	_	_	
3-21	569-571	up	_	_	
3-22	572-576	into	_	_	
3-23	577-578	a	_	_	
3-24	579-585	plasma	_	_	
3-25	586-594	fraction	_	_	
3-26	595-598	and	_	_	
3-27	599-601	an	_	_	
3-28	602-613	erythrocyte	_	_	
3-29	614-625	concentrate	_	_	
3-30	625-626	.	_	_	

#Text=The plasma is conveyed through a plasma line into a further plasma bag.
#Text=[0012] As has already been explained above, this method is technically complex because of the use of a centrifuge.
4-1	627-630	The	*[3]	4-25[4_3]	
4-2	631-637	plasma	*[3]	_	
4-3	638-640	is	*[3]	_	
4-4	641-649	conveyed	*[3]	_	
4-5	650-657	through	*[3]	_	
4-6	658-659	a	*[3]	_	
4-7	660-666	plasma	*[3]	_	
4-8	667-671	line	*[3]	_	
4-9	672-676	into	*[3]	_	
4-10	677-678	a	*[3]	_	
4-11	679-686	further	*[3]	_	
4-12	687-693	plasma	*[3]	_	
4-13	694-697	bag	*[3]	_	
4-14	697-698	.	*[3]	_	
4-15	699-700	[	_	_	
4-16	700-704	0012	_	_	
4-17	704-705	]	_	_	
4-18	706-708	As	_	_	
4-19	709-712	has	_	_	
4-20	713-720	already	_	_	
4-21	721-725	been	_	_	
4-22	726-735	explained	_	_	
4-23	736-741	above	_	_	
4-24	741-742	,	_	_	
4-25	743-747	this	*[4]	_	
4-26	748-754	method	*[4]	_	
4-27	755-757	is	_	_	
4-28	758-769	technically	_	_	
4-29	770-777	complex	_	_	
4-30	778-785	because	_	_	
4-31	786-788	of	_	_	
4-32	789-792	the	_	_	
4-33	793-796	use	_	_	
4-34	797-799	of	_	_	
4-35	800-801	a	_	_	
4-36	802-812	centrifuge	_	_	
4-37	812-813	.	_	_	

#Text=Moreover, the plasma cannot be separated completely, because there may otherwise be a danger of mixing with erythrocytes.
#Text=[0013] U.S.
5-1	814-822	Moreover	_	_	
5-2	822-823	,	_	_	
5-3	824-827	the	_	_	
5-4	828-834	plasma	_	_	
5-5	835-841	cannot	_	_	
5-6	842-844	be	_	_	
5-7	845-854	separated	_	_	
5-8	855-865	completely	_	_	
5-9	865-866	,	_	_	
5-10	867-874	because	_	_	
5-11	875-880	there	_	_	
5-12	881-884	may	_	_	
5-13	885-894	otherwise	_	_	
5-14	895-897	be	_	_	
5-15	898-899	a	_	_	
5-16	900-906	danger	_	_	
5-17	907-909	of	_	_	
5-18	910-916	mixing	_	_	
5-19	917-921	with	_	_	
5-20	922-934	erythrocytes	_	_	
5-21	934-935	.	_	_	
5-22	936-937	[	_	_	
5-23	937-941	0013	_	_	
5-24	941-942	]	_	_	
5-25	943-946	U.S	_	_	
5-26	946-947	.	_	_	

#Text=Pat.
6-1	948-951	Pat	_	_	
6-2	951-952	.	_	_	

#Text=No. 5,527,472 likewise describes a closed system for separation of whole-blood constituents by means of centrifugation.
7-1	953-955	No	_	_	
7-2	955-956	.	_	_	
7-3	957-966	5,527,472	_	_	
7-4	967-975	likewise	_	_	
7-5	976-985	describes	_	_	
7-6	986-987	a	_	_	
7-7	988-994	closed	_	_	
7-8	995-1001	system	_	_	
7-9	1002-1005	for	_	_	
7-10	1006-1016	separation	_	_	
7-11	1017-1019	of	_	_	
7-12	1020-1031	whole-blood	_	_	
7-13	1032-1044	constituents	_	_	
7-14	1045-1047	by	_	_	
7-15	1048-1053	means	_	_	
7-16	1054-1056	of	_	_	
7-17	1057-1071	centrifugation	_	_	
7-18	1071-1072	.	_	_	

#Text=In this method, the centrifugation initially takes place in a first bag with division into plasma and an erythrocyte concentrate, to which a substitute solution is then mixed.
8-1	1073-1075	In	_	_	
8-2	1076-1080	this	_	_	
8-3	1081-1087	method	_	_	
8-4	1087-1088	,	_	_	
8-5	1089-1092	the	_	_	
8-6	1093-1107	centrifugation	_	_	
8-7	1108-1117	initially	_	_	
8-8	1118-1123	takes	_	_	
8-9	1124-1129	place	_	_	
8-10	1130-1132	in	_	_	
8-11	1133-1134	a	_	_	
8-12	1135-1140	first	_	_	
8-13	1141-1144	bag	_	_	
8-14	1145-1149	with	_	_	
8-15	1150-1158	division	_	_	
8-16	1159-1163	into	_	_	
8-17	1164-1170	plasma	_	_	
8-18	1171-1174	and	_	_	
8-19	1175-1177	an	_	_	
8-20	1178-1189	erythrocyte	_	_	
8-21	1190-1201	concentrate	_	_	
8-22	1201-1202	,	_	_	
8-23	1203-1205	to	_	_	
8-24	1206-1211	which	_	_	
8-25	1212-1213	a	_	_	
8-26	1214-1224	substitute	_	_	
8-27	1225-1233	solution	_	_	
8-28	1234-1236	is	_	_	
8-29	1237-1241	then	_	_	
8-30	1242-1247	mixed	_	_	
8-31	1247-1248	.	_	_	

#Text=This mixture is then freed of leukocytes in a leukocyte-removing filter, so that an erythrocyte concentrate with substitute solution is obtained, but which still contains a high proportion of plasma.
#Text=[0014] This method too is technically complex, and a high proportion of blood plasma remains in the erythrocyte concentrate.
9-1	1249-1253	This	*[5]	9-37[6_5]	
9-2	1254-1261	mixture	*[5]	_	
9-3	1262-1264	is	*[5]	_	
9-4	1265-1269	then	*[5]	_	
9-5	1270-1275	freed	*[5]	_	
9-6	1276-1278	of	*[5]	_	
9-7	1279-1289	leukocytes	*[5]	_	
9-8	1290-1292	in	*[5]	_	
9-9	1293-1294	a	*[5]	_	
9-10	1295-1313	leukocyte-removing	*[5]	_	
9-11	1314-1320	filter	*[5]	_	
9-12	1320-1321	,	*[5]	_	
9-13	1322-1324	so	*[5]	_	
9-14	1325-1329	that	*[5]	_	
9-15	1330-1332	an	*[5]	_	
9-16	1333-1344	erythrocyte	*[5]	_	
9-17	1345-1356	concentrate	*[5]	_	
9-18	1357-1361	with	*[5]	_	
9-19	1362-1372	substitute	*[5]	_	
9-20	1373-1381	solution	*[5]	_	
9-21	1382-1384	is	*[5]	_	
9-22	1385-1393	obtained	*[5]	_	
9-23	1393-1394	,	*[5]	_	
9-24	1395-1398	but	*[5]	_	
9-25	1399-1404	which	*[5]	_	
9-26	1405-1410	still	*[5]	_	
9-27	1411-1419	contains	*[5]	_	
9-28	1420-1421	a	*[5]	_	
9-29	1422-1426	high	*[5]	_	
9-30	1427-1437	proportion	*[5]	_	
9-31	1438-1440	of	*[5]	_	
9-32	1441-1447	plasma	*[5]	_	
9-33	1447-1448	.	*[5]	_	
9-34	1449-1450	[	_	_	
9-35	1450-1454	0014	_	_	
9-36	1454-1455	]	_	_	
9-37	1456-1460	This	*[6]	_	
9-38	1461-1467	method	*[6]	_	
9-39	1468-1471	too	_	_	
9-40	1472-1474	is	_	_	
9-41	1475-1486	technically	_	_	
9-42	1487-1494	complex	_	_	
9-43	1494-1495	,	_	_	
9-44	1496-1499	and	_	_	
9-45	1500-1501	a	_	_	
9-46	1502-1506	high	_	_	
9-47	1507-1517	proportion	_	_	
9-48	1518-1520	of	_	_	
9-49	1521-1526	blood	_	_	
9-50	1527-1533	plasma	_	_	
9-51	1534-1541	remains	_	_	
9-52	1542-1544	in	_	_	
9-53	1545-1548	the	_	_	
9-54	1549-1560	erythrocyte	_	_	
9-55	1561-1572	concentrate	_	_	
9-56	1572-1573	.	_	_	
